BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 33453291)

  • 1. Clinical Olfactory Working Group consensus statement on the treatment of postinfectious olfactory dysfunction.
    Addison AB; Wong B; Ahmed T; Macchi A; Konstantinidis I; Huart C; Frasnelli J; Fjaeldstad AW; Ramakrishnan VR; Rombaux P; Whitcroft KL; Holbrook EH; Poletti SC; Hsieh JW; Landis BN; Boardman J; Welge-Lüssen A; Maru D; Hummel T; Philpott CM
    J Allergy Clin Immunol; 2021 May; 147(5):1704-1719. PubMed ID: 33453291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Interpretation of the 2021 American Academy of Allergy, Asthma and Immunology expert consensus on the treatment of postinfectious olfactory dysfunction].
    Han R; Meng C; Zhu D; Xiu Q
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2023 Feb; 37(2):81-86. PubMed ID: 36756819
    [No Abstract]   [Full Text] [Related]  

  • 3. Postinfectious Olfactory Dysfunction: Oral Steroids and Olfactory Training versus Olfactory Training Alone: Is There any Benefit from Steroids?
    Genetzaki S; Tsakiropoulou E; Nikolaidis V; Markou K; Konstantinidis I
    ORL J Otorhinolaryngol Relat Spec; 2021; 83(6):387-394. PubMed ID: 34107478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative Analysis of Olfactory and Gustatory Function of Patients With COVID-19 Olfactory Dysfunction and Non-COVID-19 Postinfectious Olfactory Dysfunction.
    Jung T; Choi BY; Jang M; Kim T; Seo E; Kim JK
    J Korean Med Sci; 2023 Nov; 38(43):e352. PubMed ID: 37935167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Qualitative Olfactory Dysfunction and COVID-19: An Evidence-Based Review with Recommendations for the Clinician.
    Gary JB; Gallagher L; Joseph PV; Reed D; Gudis DA; Overdevest JB
    Am J Rhinol Allergy; 2023 Jan; 37(1):95-101. PubMed ID: 35957578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of Post-Infectious Anosmia and Hyposmia: A Systematic Review.
    Nag AK; Saltagi AK; Saltagi MZ; Wu AW; Higgins TS; Knisely A; Ting JY; Illing EA
    Ann Otol Rhinol Laryngol; 2023 Jul; 132(7):806-817. PubMed ID: 35959948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient Experiences of Postinfectious Olfactory Dysfunction.
    Philpott CM; Boardman J; Boak D
    ORL J Otorhinolaryngol Relat Spec; 2021; 83(5):299-303. PubMed ID: 33971658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Olfactory-related Quality of Life Adjustments in Smell Loss during the Coronavirus-19 Pandemic.
    Liu DT; Prem B; Besser G; Renner B; Mueller CA
    Am J Rhinol Allergy; 2022 Mar; 36(2):253-260. PubMed ID: 34704454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultramicronized Palmitoylethanolamide and Luteolin Supplement Combined with Olfactory Training to Treat Post-COVID-19 Olfactory Impairment: A Multi-Center Double-Blinded Randomized Placebo- Controlled Clinical Trial.
    Di Stadio A; D'Ascanio L; Vaira LA; Cantone E; De Luca P; Cingolani C; Motta G; De Riu G; Vitelli F; Spriano G; De Vincentiis M; Camaioni A; La Mantia I; Ferreli F; Brenner MJ
    Curr Neuropharmacol; 2022; 20(10):2001-2012. PubMed ID: 35450527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic use of steroids in non-chronic rhinosinusitis olfactory dysfunction: a systematic evidence-based review with recommendations.
    Yan CH; Overdevest JB; Patel ZM
    Int Forum Allergy Rhinol; 2019 Feb; 9(2):165-176. PubMed ID: 30472771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Olfactory dysfunction among patients with COVID-19.
    Alkholaiwi FM; Altamimi AF; Almalki HH; Almughaiseeb FA; Alsubaie SS; Alsayahi HS; Alhijli FW; Alobaishi RS; Agrawal A; Alqahtani ZA; Alotaibi FZ
    Saudi Med J; 2023 Nov; 44(11):1085-1103. PubMed ID: 37926445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of topical steroids for the treatment of olfactory disorders caused by COVID-19: A systematic review and meta-analysis.
    Kim DH; Kim SW; Kang M; Hwang SH
    Clin Otolaryngol; 2022 Jul; 47(4):509-515. PubMed ID: 35352483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parosmia is Associated with Relevant Olfactory Recovery After Olfactory Training.
    Liu DT; Sabha M; Damm M; Philpott C; Oleszkiewicz A; Hähner A; Hummel T
    Laryngoscope; 2021 Mar; 131(3):618-623. PubMed ID: 33210732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Olfactory training is helpful in postinfectious olfactory loss: a randomized, controlled, multicenter study.
    Damm M; Pikart LK; Reimann H; Burkert S; Göktas Ö; Haxel B; Frey S; Charalampakis I; Beule A; Renner B; Hummel T; Hüttenbrink KB
    Laryngoscope; 2014 Apr; 124(4):826-31. PubMed ID: 23929687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Systematic Review of the Neuropathologic Findings of Post-Viral Olfactory Dysfunction: Implications and Novel Insight for the COVID-19 Pandemic.
    Lee JC; Nallani R; Cass L; Bhalla V; Chiu AG; Villwock JA
    Am J Rhinol Allergy; 2021 May; 35(3):323-333. PubMed ID: 32915650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smell and taste dysfunction in patients with SARS-CoV-2 infection: A review of epidemiology, pathogenesis, prognosis, and treatment options.
    Kanjanaumporn J; Aeumjaturapat S; Snidvongs K; Seresirikachorn K; Chusakul S
    Asian Pac J Allergy Immunol; 2020 Jun; 38(2):69-77. PubMed ID: 32563234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Importance of Considering Olfactory Dysfunction During the COVID-19 Pandemic and in Clinical Practice.
    Desai M; Oppenheimer J
    J Allergy Clin Immunol Pract; 2021 Jan; 9(1):7-12. PubMed ID: 33130145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Ultra-Micronized Palmitoylethanolamide and Luteolin on Olfaction and Memory in Patients with Long COVID: Results of a Longitudinal Study.
    De Luca P; Camaioni A; Marra P; Salzano G; Carriere G; Ricciardi L; Pucci R; Montemurro N; Brenner MJ; Di Stadio A
    Cells; 2022 Aug; 11(16):. PubMed ID: 36010630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of new onset loss of sense of smell during the COVID-19 pandemic - BRS Consensus Guidelines.
    Hopkins C; Alanin M; Philpott C; Harries P; Whitcroft K; Qureishi A; Anari S; Ramakrishnan Y; Sama A; Davies E; Stew B; Gane S; Carrie S; Hathorn I; Bhalla R; Kelly C; Hill N; Boak D; Nirmal Kumar B
    Clin Otolaryngol; 2021 Jan; 46(1):16-22. PubMed ID: 32854169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacologic treatment for postviral olfactory dysfunction: a systematic review.
    Harless L; Liang J
    Int Forum Allergy Rhinol; 2016 Jul; 6(7):760-7. PubMed ID: 26879592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.